Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
14 drugs in development
By Therapeutic Area
top 6
R&D Momentum
95/100
Pipeline Velocity
79/100
Trial Completion Rate
87/100
Pipeline Concentration
18/100
Pipeline Freshness
53/100
Strategic Signals
Activity
Last 14 days
Early Deresuscitation Strategy Driven by Tissue Perfusion in Renal Replacement Therapy in Patients With Acute Renal Failure in Intensive Care Unit. A Randomized Study
Evaluation of Intestinal Microbiota Implication in Ruptured Intracranial Aneurysm: a Comparison of Ruptured and Unruptured Patient With Taxonomic and Metabolic Evaluation of Microbiota
Evolution of Symptoms Resistant to Removal of the Essure® Implant After Use of Transcutaneous Electrical Neurostimulation
Ultrasound Evaluation of the Quantity of Bulkamid® Peri-urethral Filler After Injection for Urinary Incontinence
Evaluation of the Benefit of Perineal Ultrasound After Injection of Bulkamid® Peri-urethral Filler for Urinary Incontinence
First Observatory of Precocious and Advanced Puberty in Private Healthcare.
Comparison of Trans-Stomial Bladder Lithotripsy Using Mini-Percutaneous Equipment Versus Trans-stomial Bladder Lithotripsy Using Flexible Fibroscope, Percutaneous Approach and Open Cystolithotomy in Patients With Continent Catheterizable Urinary Reservoir
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)